(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of CYP7A1 mRNA, epigallocatechin gallate results in increased expression of CYP7A1 protein CTD PMID:23146761 (1->4)-beta-D-glucan multiple interactions ISO RGD:10458 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA CTD PMID:36331819 (24S)-24-hydroxycholesterol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of 24-hydroxycholesterol CTD PMID:11013305 (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 (E)-thiamethoxam decreases expression ISO RGD:69210 6480464 Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:10458 6480464 o, p'-DDT affects the expression of CYP7A1 mRNA CTD PMID:18925944 1,2-dichloroethane decreases expression ISO RGD:10458 6480464 ethylene dichloride results in decreased expression of CYP7A1 mRNA CTD PMID:28189721 , PMID:28960355 1,3,7,9-tetramethyluric acid multiple interactions EXP 6480464 1 more ... CTD PMID:35872049 1,4-dithiothreitol increases activity EXP 6480464 Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA, 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein CTD PMID:14623915 more ... 1-naphthyl isothiocyanate multiple interactions ISO RGD:69210 6480464 4-methyl-7, 8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] CTD PMID:36581201 1-naphthyl isothiocyanate increases expression ISO RGD:69210 6480464 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein CTD PMID:36581201 1-naphthyl isothiocyanate decreases expression EXP 15090803 1-naphthyl isothiocyanate decreases expression of Cyp7a1 protein in rat liver RGD 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP7A1 mRNA CTD PMID:20551477 more ... 1-naphthyl isothiocyanate decreases expression ISO RGD:10458 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA, 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein CTD PMID:25655198 more ... 1-naphthyl isothiocyanate multiple interactions ISO RGD:10458 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:25655198 more ... 1-naphthyl isothiocyanate multiple interactions EXP 6480464 resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA], resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] CTD PMID:25418378 17alpha-ethynylestradiol multiple interactions ISO RGD:10458 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:16606610 more ... 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP7A1 protein CTD PMID:11473529 , PMID:9869655 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:16487557 more ... 17alpha-ethynylestradiol multiple interactions EXP 6480464 3 more ... CTD PMID:12963437 , PMID:16487557 17alpha-ethynylestradiol decreases expression ISO RGD:10458 6480464 Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA, Ethinyl Estradiol results in decreased expression of CYP7A1 protein CTD PMID:16606610 more ... 17beta-estradiol decreases expression ISO RGD:69210 6480464 Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:10458 6480464 Estradiol results in increased expression of CYP7A1 mRNA, Estradiol results in increased expression of CYP7A1 protein CTD PMID:35802278 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:32145629 1H-pyrazole decreases expression ISO RGD:10458 6480464 pyrazole results in decreased expression of CYP7A1 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10458 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:23756648 more ... 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:20056577 , PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:10458 6480464 2 more ... CTD PMID:30294300 , PMID:33078840 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69210 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10458 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:23756648 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69210 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:16054898 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10458 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10458 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA CTD PMID:21095216 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:10458 6480464 2 more ... CTD PMID:25768209 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of CYP7A1 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CYP7A1 mRNA CTD PMID:21346803 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA CTD PMID:14656948 , PMID:16158176 2-arachidonoylglycerol multiple interactions ISO RGD:10458 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] CTD PMID:23894352 2-arachidonoylglycerol increases expression ISO RGD:69210 6480464 glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA CTD PMID:23894352 2-arachidonoylglycerol multiple interactions ISO RGD:69210 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] more ... CTD PMID:23894352 2-arachidonoylglycerol increases expression ISO RGD:10458 6480464 glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA CTD PMID:23894352 , PMID:28095641 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:10458 6480464 geranylgeranyl pyrophosphate inhibits the reaction [resveratrol results in increased expression of CYP7A1 mRNA] CTD PMID:22607622 20-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol CTD PMID:10882719 20-hydroxycholesterol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol CTD PMID:10882719 25-hydroxycholesterol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol CTD PMID:10882719 25-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol CTD PMID:10882719 26-hydroxycholesterol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 26-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:69210 6480464 3 more ... CTD PMID:23146750 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:10458 6480464 3 more ... CTD PMID:19467301 3-phenylprop-2-enal increases expression ISO RGD:69210 6480464 cinnamaldehyde results in increased expression of CYP7A1 mRNA CTD PMID:19000754 4,4'-sulfonyldiphenol decreases methylation ISO RGD:10458 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of CYP7A1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:10458 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CYP7A1 gene CTD PMID:31683443 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:10458 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:33749747 7-ketocholesterol decreases activity EXP 6480464 7-ketocholesterol results in decreased activity of CYP7A1 protein CTD PMID:1175606 7alpha-hydroxycholesterol multiple interactions EXP 6480464 [Uranyl Nitrate results in decreased activity of CYP7A1 protein] which results in decreased chemical synthesis of cholest-5-en-3 beta, 7 alpha-diol CTD PMID:20362056 8-Epidiosbulbin E acetate decreases expression ISO RGD:10458 6480464 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 mRNA, 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 protein CTD PMID:31626840 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CYP7A1 mRNA CTD PMID:15749267 acrylamide decreases expression ISO RGD:10458 6480464 Acrylamide results in decreased expression of CYP7A1 mRNA CTD PMID:34896238 acrylamide multiple interactions ISO RGD:10458 6480464 Acrylamide inhibits the reaction [Streptozocin results in increased expression of CYP7A1 mRNA] CTD PMID:34896238 Actein increases expression EXP 6480464 actein results in increased expression of CYP7A1 mRNA CTD PMID:19527300 aflatoxin B1 affects expression ISO RGD:69210 6480464 Aflatoxin B1 affects the expression of CYP7A1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:10458 6480464 Aflatoxin B1 results in increased expression of CYP7A1 mRNA, Aflatoxin B1 results in increased expression of CYP7A1 protein CTD PMID:37030333 aflatoxin B1 multiple interactions ISO RGD:10458 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] CTD PMID:37030333 aflatoxin B1 decreases expression ISO RGD:69210 6480464 Aflatoxin B1 results in decreased expression of CYP7A1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression ISO RGD:10458 6480464 Aflatoxin B1 results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 alfacalcidol increases expression ISO RGD:10458 6480464 alfacalcidol results in increased expression of CYP7A1 mRNA CTD PMID:19581390 all-trans-retinoic acid multiple interactions ISO RGD:69210 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:21274875 , PMID:30709899 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP7A1 mRNA CTD PMID:24977338 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:21274875 all-trans-retinoic acid decreases expression ISO RGD:69210 6480464 Tretinoin results in decreased expression of CYP7A1 mRNA, Tretinoin results in decreased expression of CYP7A1 protein CTD PMID:21274875 , PMID:30709899 allopurinol multiple interactions ISO RGD:10458 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of CYP7A1 mRNA CTD PMID:33749747 AM-251 multiple interactions ISO RGD:10458 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] CTD PMID:23894352 , PMID:28095641 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of CYP7A1 mRNA CTD PMID:22291062 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP7A1 mRNA CTD PMID:16483693 amphibole asbestos affects expression ISO RGD:69210 6480464 Asbestos, Amphibole affects the expression of CYP7A1 protein CTD PMID:20855422 amphotericin B multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA CTD PMID:36464106 ampicillin multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA CTD PMID:36464106 angelicin decreases expression EXP 6480464 angelicin results in decreased expression of CYP7A1 mRNA, angelicin results in decreased expression of CYP7A1 protein CTD PMID:30597224 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69210 6480464 pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA], pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 protein] CTD PMID:30709899 arsane multiple interactions ISO RGD:10458 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA CTD PMID:22719926 arsenic atom multiple interactions ISO RGD:10458 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA CTD PMID:22719926 atazanavir sulfate multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO RGD:69210 6480464 Atazanavir Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 atorvastatin calcium increases expression ISO RGD:10458 6480464 Atorvastatin results in increased expression of CYP7A1 mRNA CTD PMID:25278499 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA] CTD PMID:32048413 atrazine increases expression ISO RGD:10458 6480464 Atrazine results in increased expression of CYP7A1 mRNA CTD PMID:22515965 Augmentin decreases expression ISO RGD:69210 6480464 Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 azoxystrobin decreases expression ISO RGD:69210 6480464 azoxystrobin results in decreased expression of CYP7A1 mRNA, azoxystrobin results in decreased expression of CYP7A1 protein CTD PMID:32194361 Benoxacor increases expression ISO RGD:10458 6480464 benoxacor results in increased expression of CYP7A1 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO RGD:10458 6480464 Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:69210 6480464 Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:10458 6480464 [corannulene co-treated with Benzo(a)pyrene] results in increased expression of CYP7A1 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:69210 6480464 Benzo(a)pyrene results in decreased methylation of CYP7A1 promoter CTD PMID:27901495 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of CYP7A1 mRNA CTD PMID:22374506 beta-hexachlorocyclohexane increases expression ISO RGD:69210 6480464 beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA CTD PMID:28392238 beta-hexachlorocyclohexane increases expression ISO RGD:10458 6480464 beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA CTD PMID:28392238 beta-naphthoflavone decreases expression ISO RGD:69210 6480464 beta-Naphthoflavone results in decreased expression of CYP7A1 mRNA CTD PMID:22258563 bezafibrate decreases activity ISO RGD:69210 6480464 Bezafibrate results in decreased activity of CYP7A1 protein CTD PMID:2044640 bezafibrate decreases activity EXP 6480464 Bezafibrate results in decreased activity of CYP7A1 protein CTD PMID:2044640 bezafibrate decreases expression ISO RGD:69210 6480464 Bezafibrate results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 bilirubin IXalpha multiple interactions EXP 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 bilirubin IXalpha decreases activity EXP 6480464 Bilirubin results in decreased activity of CYP7A1 protein CTD PMID:12700418 bis(2-ethylhexyl) phthalate increases expression ISO RGD:10458 6480464 Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA CTD PMID:29945229 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10458 6480464 [APOE gene mutant form results in increased susceptibility to Diethylhexyl Phthalate] which results in decreased expression of CYP7A1 protein more ... CTD PMID:19850644 more ... bisphenol A increases expression ISO RGD:10458 6480464 bisphenol A results in increased expression of CYP7A1 mRNA CTD PMID:17706920 , PMID:27502578 bisphenol A decreases expression ISO RGD:10458 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:32156529 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP7A1 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:25181051 more ... bisphenol A decreases expression ISO RGD:69210 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:23146750 bisphenol A multiple interactions ISO RGD:10458 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17706920 more ... bosentan decreases expression ISO RGD:69210 6480464 Bosentan results in decreased expression of CYP7A1 mRNA CTD PMID:29761207 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CYP7A1 mRNA CTD PMID:32479839 cadmium atom multiple interactions ISO RGD:69210 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA CTD PMID:35301059 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CYP7A1 promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:69210 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA CTD PMID:35301059 calcipotriol decreases expression ISO RGD:69210 6480464 calcipotriene results in decreased expression of CYP7A1 protein CTD PMID:30419252 calcipotriol multiple interactions ISO RGD:69210 6480464 calcipotriene inhibits the reaction [VDR protein affects the expression of CYP7A1 protein] CTD PMID:30419252 calcitriol multiple interactions ISO RGD:69210 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:19106115 , PMID:20371703 calcitriol decreases expression ISO RGD:69210 6480464 Calcitriol results in decreased expression of CYP7A1 mRNA CTD PMID:20371703 carbendazim decreases expression ISO RGD:69210 6480464 carbendazim results in decreased expression of CYP7A1 mRNA, carbendazim results in decreased expression of CYP7A1 protein CTD PMID:32194361 carbon nanotube affects expression ISO RGD:10458 6480464 Nanotubes, Carbon analog affects the expression of CYP7A1 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:10458 6480464 Nanotubes, Carbon results in decreased expression of CYP7A1 mRNA CTD PMID:25620056 chenodeoxycholic acid decreases expression ISO RGD:69210 6480464 Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:19072826 more ... chenodeoxycholic acid decreases expression ISO RGD:10458 6480464 Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:19072826 more ... chenodeoxycholic acid multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:17963371 more ... chenodeoxycholic acid multiple interactions EXP 6480464 [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA, [Chenodeoxycholic Acid results in increased expression of FGF19 protein] which results in decreased expression of CYP7A1 protein CTD PMID:20835427 , PMID:30985903 chenodeoxycholic acid multiple interactions ISO RGD:10458 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA], NR1H4 mutant form inhibits the reaction [Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:19072826 , PMID:35780845 chitosan multiple interactions EXP 6480464 Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA], Fish Oils promotes the reaction [Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]] CTD PMID:28987369 chlormequat chloride increases expression ISO RGD:69210 6480464 Chlormequat results in increased expression of CYP7A1 protein CTD PMID:32194361 chloroquine multiple interactions ISO RGD:69210 6480464 Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form], CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] CTD PMID:28275691 chlorpyrifos increases expression ISO RGD:10458 6480464 Chlorpyrifos results in increased expression of CYP7A1 mRNA CTD PMID:32715474 chlorpyrifos decreases expression ISO RGD:69210 6480464 Chlorpyrifos results in decreased expression of CYP7A1 mRNA, Chlorpyrifos results in decreased expression of CYP7A1 protein CTD PMID:32194361 cholate decreases expression ISO RGD:69210 6480464 Cholates results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 cholate decreases expression ISO RGD:10458 6480464 Cholates results in decreased expression of CYP7A1 CTD PMID:10809780 cholesta-5,7-dien-3beta-ol decreases activity EXP 6480464 7-dehydrocholesterol results in decreased activity of CYP7A1 protein CTD PMID:1175606 cholesterol affects metabolic processing ISO RGD:69210 6480464 CYP7A1 protein affects the metabolism of Cholesterol CTD PMID:15696852 cholesterol multiple interactions ISO RGD:69210 6480464 CYP7A1 mRNA inhibits the reaction [Cholesterol results in increased phosphorylation of EIF4EBP1 protein] more ... CTD PMID:28275691 , PMID:30709899 cholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of Cholesterol CTD PMID:1175606 cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of CYP7A1 mRNA CTD PMID:21535835 cholesterol multiple interactions EXP 6480464 turmeric extract promotes the reaction [Cholesterol results in increased expression of CYP7A1 mRNA] CTD PMID:21535835 cholesterol increases metabolic processing ISO RGD:69210 6480464 CYP7A1 protein results in increased metabolism of Cholesterol CTD PMID:11013305 , PMID:7925343 cholic acid decreases expression ISO RGD:69210 6480464 Cholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:25055961 cholic acid decreases expression ISO RGD:10458 6480464 Cholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:12072388 more ... cholic acid multiple interactions ISO RGD:10458 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA CTD PMID:22540009 cholic acid multiple interactions EXP 6480464 [Cholesterol more ... CTD PMID:14684380 chrysophanol increases expression EXP 6480464 chrysophanic acid results in increased expression of CYP7A1 mRNA, chrysophanic acid results in increased expression of CYP7A1 protein CTD PMID:28161596 ciguatoxin CTX1B affects expression ISO RGD:10458 6480464 Ciguatoxins affects the expression of CYP7A1 mRNA CTD PMID:18353800 clavulanic acid decreases expression ISO RGD:69210 6480464 Clavulanic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 clofibrate decreases expression ISO RGD:10458 6480464 Clofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 clofibrate increases expression ISO RGD:10458 6480464 Clofibrate results in increased expression of CYP7A1 mRNA CTD PMID:28973556 clothianidin decreases expression EXP 6480464 clothianidin results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 clothianidin multiple interactions EXP 6480464 [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA, [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 cobalt atom increases expression ISO RGD:10458 6480464 Cobalt results in increased expression of CYP7A1 mRNA CTD PMID:22147119 copper atom decreases expression ISO RGD:10458 6480464 Copper results in decreased expression of CYP7A1 mRNA CTD PMID:17205981 copper atom decreases activity EXP 6480464 Copper results in decreased activity of CYP7A1 protein CTD PMID:1175606 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of CYP7A1 mRNA CTD PMID:11110846 copper(0) decreases expression ISO RGD:10458 6480464 Copper results in decreased expression of CYP7A1 mRNA CTD PMID:17205981 copper(0) decreases activity EXP 6480464 Copper results in decreased activity of CYP7A1 protein CTD PMID:1175606 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of CYP7A1 mRNA CTD PMID:11110846 copper(II) sulfate decreases expression ISO RGD:69210 6480464 Copper Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:19549813 corn oil affects expression EXP 6480464 Corn Oil affects the expression of CYP7A1 mRNA CTD PMID:16360708 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of CYP7A1 mRNA CTD PMID:18480146 cyclosporin A decreases expression ISO RGD:69210 6480464 Cyclosporine results in decreased expression of CYP7A1 mRNA, Cyclosporine results in decreased expression of CYP7A1 protein CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:69210 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA, [Cyclosporine results in decreased expression of CYP7A1 protein] which affects the abundance of Cholic Acids CTD PMID:26198044 , PMID:32152650 cyclosporin A increases expression ISO RGD:10458 6480464 Cyclosporine results in increased expression of CYP7A1 mRNA CTD PMID:19770486 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA CTD PMID:29038839 cyproconazole decreases expression ISO RGD:69210 6480464 cyproconazole results in decreased expression of CYP7A1 mRNA CTD PMID:29995386 cyprodinil decreases expression ISO RGD:69210 6480464 cyprodinil results in decreased expression of CYP7A1 mRNA, cyprodinil results in decreased expression of CYP7A1 protein CTD PMID:32194361 cysteamine increases activity EXP 6480464 Cysteamine results in increased activity of CYP7A1 protein CTD PMID:1175606 DDE increases expression ISO RGD:69210 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:28392238 DDE increases expression ISO RGD:10458 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:28392238 deoxycholic acid decreases expression ISO RGD:69210 6480464 Deoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 , PMID:25055961 deoxycholic acid multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 , PMID:33819548 deoxycholic acid decreases expression ISO RGD:10458 6480464 Deoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20671298 more ... deoxycholic acid decreases activity EXP 6480464 Deoxycholic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 deoxycholic acid multiple interactions ISO RGD:10458 6480464 [Deoxycholic Acid results in increased activity of NR1H4 protein] which results in increased expression of CYP7A1 mRNA, SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:21914718 , PMID:22531947 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP7A1 mRNA CTD PMID:15965953 , PMID:32599024 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP7A1 mRNA CTD PMID:20888898 dextran sulfate decreases expression ISO RGD:10458 6480464 Dextran Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:27580383 diallyl trisulfide decreases expression ISO RGD:69210 6480464 diallyl trisulfide results in decreased expression of CYP7A1 mRNA CTD PMID:16382202 dichloroacetic acid increases expression ISO RGD:10458 6480464 Dichloroacetic Acid results in increased expression of CYP7A1 mRNA CTD PMID:28962523 , PMID:34850242 diclofenac increases expression ISO RGD:10458 6480464 Diclofenac results in increased expression of CYP7A1 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:69210 6480464 dicrotophos results in decreased expression of CYP7A1 mRNA CTD PMID:28302478 difenoconazole decreases expression ISO RGD:69210 6480464 difenoconazole results in decreased expression of CYP7A1 mRNA, difenoconazole results in decreased expression of CYP7A1 protein CTD PMID:32194361 dihydroartemisinin multiple interactions EXP 15036816 Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] RGD dihydroxyacetone decreases expression ISO RGD:69210 6480464 Dihydroxyacetone results in decreased expression of CYP7A1 mRNA CTD PMID:32506039 Diisodecyl phthalate increases expression ISO RGD:10458 6480464 diisodecyl phthalate results in increased expression of CYP7A1 mRNA CTD PMID:25270620 dimethomorph decreases expression ISO RGD:69210 6480464 dimethomorph results in decreased expression of CYP7A1 mRNA, dimethomorph results in decreased expression of CYP7A1 protein CTD PMID:32194361 dimethyl sulfoxide increases expression EXP 15092090 DMSO increases expression of Cyp7a1 mRNA in rat liver, reaction inhibited by INT-767 RGD Diosbulbin B decreases expression ISO RGD:10458 6480464 diosbulbin B results in decreased expression of CYP7A1 mRNA CTD PMID:32148032 Diosbulbin B decreases activity ISO RGD:10458 6480464 diosbulbin B results in decreased activity of CYP7A1 protein CTD PMID:32148032 diosgenin multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of CYP7A1 mRNA more ... CTD PMID:12963437 , PMID:33383043 dioxygen decreases expression ISO RGD:69210 6480464 Oxygen deficiency results in decreased expression of CYP7A1 mRNA CTD PMID:19695866 disodium selenite multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 elemental selenium multiple interactions EXP 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 elemental selenium multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 emodin decreases expression EXP 6480464 Emodin results in decreased expression of CYP7A1 mRNA, Emodin results in decreased expression of CYP7A1 protein CTD PMID:28161596 emodin multiple interactions EXP 6480464 [2 more ... CTD PMID:35753641 endosulfan multiple interactions ISO RGD:69210 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYP7A1 mRNA CTD PMID:29391264 endosulfan decreases expression ISO RGD:69210 6480464 Endosulfan results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 enilconazole multiple interactions EXP 6480464 [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA, [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 enilconazole decreases expression ISO RGD:69210 6480464 enilconazole results in decreased expression of CYP7A1 mRNA, enilconazole results in decreased expression of CYP7A1 protein CTD PMID:32194361 , PMID:32201337 enilconazole decreases expression ISO RGD:10458 6480464 enilconazole results in decreased expression of CYP7A1 mRNA CTD PMID:29451352 , PMID:32814239 Epomediol increases activity EXP 6480464 epomediol results in increased activity of CYP7A1 protein CTD PMID:10961725 , PMID:11473529 Epomediol increases expression EXP 6480464 epomediol results in increased expression of CYP7A1 mRNA CTD PMID:11473529 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA CTD PMID:29038839 epoxiconazole decreases expression ISO RGD:10458 6480464 epoxiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:35436446 epoxiconazole decreases expression ISO RGD:69210 6480464 epoxiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 ethambutol multiple interactions ISO RGD:69210 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein CTD PMID:35835356 ethambutol multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 ethanol multiple interactions EXP 6480464 1 more ... CTD PMID:17347304 , PMID:35872049 ethanol increases expression EXP 15036816 ethanol increases expression of Cyp7a1 protein in liver RGD ethanol increases expression ISO RGD:10458 6480464 Ethanol results in increased expression of CYP7A1 mRNA, Ethanol results in increased expression of CYP7A1 protein CTD PMID:19167417 more ... ethanol multiple interactions ISO RGD:10458 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... CTD PMID:23894352 , PMID:28095641 ethoprophos decreases expression ISO RGD:69210 6480464 ethoprop results in decreased expression of CYP7A1 mRNA, ethoprop results in decreased expression of CYP7A1 protein CTD PMID:32194361 fenbuconazole decreases expression ISO RGD:69210 6480464 fenbuconazole results in decreased expression of CYP7A1 mRNA CTD PMID:15942997 fenhexamid decreases expression ISO RGD:69210 6480464 N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA CTD PMID:18253720 fenofibrate decreases expression ISO RGD:69210 6480464 Fenofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 fenpyroximate decreases expression ISO RGD:69210 6480464 fenpyroximate results in decreased expression of CYP7A1 mRNA, fenpyroximate results in decreased expression of CYP7A1 protein CTD PMID:32194361 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of CYP7A1 mRNA CTD PMID:30307764 Fexaramine multiple interactions ISO RGD:10458 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] CTD PMID:37030333 fipronil decreases expression ISO RGD:69210 6480464 fipronil results in decreased expression of CYP7A1 protein CTD PMID:32194361 fipronil increases expression ISO RGD:69210 6480464 fipronil results in increased expression of CYP7A1 mRNA CTD PMID:32194361 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] CTD PMID:23524313 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CYP7A1 mRNA CTD PMID:18035473 fludioxonil decreases expression ISO RGD:69210 6480464 fludioxonil results in decreased expression of CYP7A1 protein CTD PMID:32194361 flusilazole decreases expression ISO RGD:69210 6480464 flusilazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP7A1 mRNA CTD PMID:24136188 fluxapyroxad decreases expression ISO RGD:69210 6480464 fluxapyroxad results in decreased expression of CYP7A1 mRNA, fluxapyroxad results in decreased expression of CYP7A1 protein CTD PMID:32194361 furan decreases expression EXP 6480464 furan results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 furan decreases expression ISO RGD:10458 6480464 furan results in decreased expression of CYP7A1 mRNA CTD PMID:32251705 furan multiple interactions ISO RGD:10458 6480464 rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] CTD PMID:32251705 furan increases expression EXP 6480464 furan results in increased expression of CYP7A1 mRNA CTD PMID:25539665 gemfibrozil decreases expression ISO RGD:69210 6480464 Gemfibrozil results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA CTD PMID:21782745 Gentiopicrin decreases expression EXP 15045612 Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liver RGD glycochenodeoxycholic acid multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycocholic acid multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:69210 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycyrrhetinate multiple interactions ISO RGD:10458 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 glycyrrhetinic acid multiple interactions ISO RGD:10458 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 glycyrrhizinic acid multiple interactions ISO RGD:10458 6480464 Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 glycyrrhizinic acid decreases expression ISO RGD:10458 6480464 Glycyrrhizic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:22982774 gold atom increases expression ISO RGD:69210 6480464 Gold analog results in increased expression of CYP7A1 mRNA CTD PMID:36057382 gold(0) increases expression ISO RGD:69210 6480464 Gold analog results in increased expression of CYP7A1 mRNA CTD PMID:36057382 graphene oxide increases expression ISO RGD:10458 6480464 graphene oxide results in increased expression of CYP7A1 mRNA CTD PMID:33227293 guggulsterone multiple interactions EXP 15036816 Z-guggulsterone reverses the reaction [Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver]] RGD guggulsterone multiple interactions ISO RGD:10458 6480464 pregna-4 more ... CTD PMID:25655198 , PMID:29660435 guggulsterone multiple interactions ISO RGD:69210 6480464 pregna-4 more ... CTD PMID:12705905 GW 3965 increases expression EXP 6480464 GW 3965 results in increased expression of CYP7A1 mRNA CTD PMID:17420776 GW 4064 decreases expression ISO RGD:69210 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:31437187 GW 4064 decreases expression EXP 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:14623915 , PMID:15644430 GW 4064 decreases expression ISO RGD:10458 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:27609522 , PMID:36511616 GW 4064 multiple interactions ISO RGD:10458 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA more ... CTD PMID:22467244 more ... Heliotrine decreases expression ISO RGD:69210 6480464 heliotrine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 hyperforin decreases expression ISO RGD:69210 6480464 hyperforin results in decreased expression of CYP7A1 mRNA CTD PMID:24259679 icariside II increases expression ISO RGD:10458 6480464 baohuoside I results in increased expression of CYP7A1 mRNA, baohuoside I results in increased expression of CYP7A1 protein CTD PMID:35802278 icariside II increases expression ISO RGD:69210 6480464 baohuoside I results in increased expression of CYP7A1 mRNA, baohuoside I results in increased expression of CYP7A1 protein CTD PMID:35802278 imipenem hydrate multiple interactions ISO RGD:10458 6480464 [Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA CTD PMID:24657338 indoxyl sulfate decreases expression ISO RGD:69210 6480464 Indican results in decreased expression of CYP7A1 mRNA CTD PMID:30639138 iprodione decreases expression ISO RGD:69210 6480464 iprodione results in decreased expression of CYP7A1 protein CTD PMID:32194361 isoniazide multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein more ... CTD PMID:25331106 more ... isoniazide multiple interactions ISO RGD:69210 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein, [Isoniazid co-treated with Vitamin B 6] results in increased expression of CYP7A1 mRNA CTD PMID:32673658 , PMID:35835356 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of CYP7A1 mRNA CTD PMID:25331106 , PMID:32673658 kaempferol multiple interactions ISO RGD:69210 6480464 kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] CTD PMID:36150480 ketoconazole multiple interactions EXP 6480464 [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:30985903 ketoconazole increases expression ISO RGD:10458 6480464 Ketoconazole results in increased expression of CYP7A1 mRNA CTD PMID:31099283 kojic acid multiple interactions ISO RGD:10458 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA, [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA CTD PMID:17917374 L-1,4-dithiothreitol increases activity EXP 6480464 Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 L-ascorbic acid multiple interactions ISO RGD:10458 6480464 [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA, [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA CTD PMID:17917374 Lasiocarpine decreases expression ISO RGD:69210 6480464 lasiocarpine results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 lead nitrate decreases expression ISO RGD:10458 6480464 lead nitrate results in decreased expression of CYP7A1 mRNA CTD PMID:16049268 , PMID:22293356 lead nitrate multiple interactions ISO RGD:10458 6480464 [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] CTD PMID:22293356 lead nitrate decreases expression EXP 6480464 lead nitrate results in decreased expression of CYP7A1 mRNA CTD PMID:15475176 lead(0) multiple interactions EXP 6480464 puerarin affects the reaction [Lead affects the expression of CYP7A1] CTD PMID:22001170 lead(0) decreases activity EXP 6480464 Lead results in decreased activity of CYP7A1 protein CTD PMID:1175606 lead(0) affects expression EXP 6480464 Lead affects the expression of CYP7A1 CTD PMID:22001170 lipopolysaccharide multiple interactions ISO RGD:69210 6480464 [S-(1 more ... CTD PMID:22777745 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:69210 6480464 Lipopolysaccharides results in increased expression of CYP7A1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Isoniazid] results in increased expression of CYP7A1 mRNA CTD PMID:25331106 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CYP7A1 mRNA CTD PMID:25331106 lithocholic acid decreases expression ISO RGD:69210 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:25055961 lithocholic acid decreases expression ISO RGD:10458 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:16436656 more ... lithocholic acid multiple interactions ISO RGD:69210 6480464 [Lithocholic Acid analog binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA, [Lithocholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA CTD PMID:17963371 lithocholic acid decreases activity EXP 6480464 Lithocholic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20888898 lithocholic acid multiple interactions ISO RGD:10458 6480464 1 more ... CTD PMID:19196849 more ... loperamide increases expression ISO RGD:10458 6480464 Loperamide results in increased expression of CYP7A1 mRNA CTD PMID:35926757 magnesium atom multiple interactions EXP 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 maneb decreases expression ISO RGD:69210 6480464 Maneb results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 manganese atom multiple interactions EXP 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 manganese atom increases activity EXP 6480464 Manganese results in increased activity of CYP7A1 protein CTD PMID:12700418 manganese(0) multiple interactions EXP 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 manganese(0) increases activity EXP 6480464 Manganese results in increased activity of CYP7A1 protein CTD PMID:12700418 melatonin multiple interactions ISO RGD:10458 6480464 Melatonin inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... CTD PMID:28095641 melatonin decreases expression ISO RGD:10458 6480464 Melatonin results in decreased expression of CYP7A1 mRNA CTD PMID:28095641 mercaptoethanol increases activity EXP 6480464 Mercaptoethanol results in increased activity of CYP7A1 protein CTD PMID:1175606 mercury atom decreases activity EXP 6480464 Mercury results in decreased activity of CYP7A1 protein CTD PMID:1175606 mercury(0) decreases activity EXP 6480464 Mercury results in decreased activity of CYP7A1 protein CTD PMID:1175606 metacetamol decreases expression ISO RGD:10458 6480464 3-hydroxyacetanilide results in decreased expression of CYP7A1 mRNA CTD PMID:18544908 metalaxyl decreases expression ISO RGD:69210 6480464 metalaxyl results in decreased expression of CYP7A1 protein CTD PMID:32194361 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA], Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 protein] CTD PMID:31100278 metformin increases expression ISO RGD:10458 6480464 Metformin results in increased expression of CYP7A1 protein CTD PMID:34058177 metformin multiple interactions ISO RGD:10458 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA, [Metformin co-treated with Ethinyl Estradiol] results in decreased expression of CYP7A1 protein CTD PMID:34058177 metformin affects expression EXP 6480464 Metformin affects the expression of CYP7A1 mRNA CTD PMID:31324951 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP7A1 mRNA CTD PMID:30467583 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 methotrexate decreases expression ISO RGD:69210 6480464 Methotrexate results in decreased expression of CYP7A1 mRNA CTD PMID:24449571 methoxsalen decreases expression EXP 6480464 Methoxsalen results in decreased expression of CYP7A1 mRNA CTD PMID:28552422 methoxsalen decreases expression ISO RGD:69210 6480464 Methoxsalen results in decreased expression of CYP7A1 protein CTD PMID:30419252 methoxsalen multiple interactions ISO RGD:69210 6480464 Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein] CTD PMID:30419252 methoxsalen increases expression EXP 6480464 Methoxsalen results in increased expression of CYP7A1 protein CTD PMID:28552422 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA CTD PMID:21782745 metronidazole multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA CTD PMID:36464106 monocrotaline multiple interactions ISO RGD:10458 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of CYP7A1 mRNA CTD PMID:32267039 monosodium L-glutamate multiple interactions ISO RGD:10458 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP7A1 mRNA CTD PMID:20111022 monosodium L-glutamate increases expression ISO RGD:10458 6480464 Sodium Glutamate results in increased expression of CYP7A1 mRNA CTD PMID:19001666 , PMID:20111022 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP7A1 mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions ISO RGD:10458 6480464 [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA more ... CTD PMID:17917374 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYP7A1 mRNA CTD PMID:19638242 N-nitrosodiethylamine increases expression ISO RGD:10458 6480464 Diethylnitrosamine results in increased expression of CYP7A1 mRNA CTD PMID:18691550 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:14656948 more ... N-Nitrosopyrrolidine decreases expression ISO RGD:69210 6480464 N-Nitrosopyrrolidine results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 nefazodone multiple interactions ISO RGD:69210 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 nefazodone decreases expression ISO RGD:69210 6480464 nefazodone results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 neomycin multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA CTD PMID:36464106 nickel atom increases expression ISO RGD:10458 6480464 Nickel results in increased expression of CYP7A1 mRNA CTD PMID:18922574 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CYP7A1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:69210 6480464 methyleugenol results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 obeticholic acid decreases expression EXP 15045602 obeticholic acid decreases expression of CYP7a1 mRNA in liver in porcine serum induced model of cirrhosis in rat RGD obeticholic acid multiple interactions ISO RGD:10458 6480464 obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:29660435 obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA] CTD PMID:32673658 obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15644430 , PMID:35267068 obeticholic acid decreases expression ISO RGD:69210 6480464 obeticholic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15911693 , PMID:27939613 obeticholic acid multiple interactions EXP 15036816 Obeticholic acid inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] RGD okadaic acid multiple interactions ISO RGD:69210 6480464 Okadaic Acid promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA], Okadaic Acid promotes the reaction [lithocholic acid acetate results in decreased expression of CYP7A1 mRNA] CTD PMID:20371703 oleanolic acid decreases expression ISO RGD:10458 6480464 Oleanolic Acid results in decreased expression of CYP7A1 mRNA, Oleanolic Acid results in decreased expression of CYP7A1 protein CTD PMID:23948738 , PMID:37028458 oleanolic acid multiple interactions ISO RGD:10458 6480464 GW 4064 inhibits the reaction [Oleanolic Acid results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:37028458 oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:32738331 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CYP7A1 mRNA CTD PMID:23665939 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CYP7A1 mRNA CTD PMID:30316929 p-chloromercuribenzoic acid decreases activity EXP 6480464 p-Chloromercuribenzoic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of CYP7A1 mRNA CTD PMID:15585946 paracetamol affects expression ISO RGD:10458 6480464 Acetaminophen affects the expression of CYP7A1 mRNA CTD PMID:15030884 , PMID:17562736 paracetamol increases expression ISO RGD:69210 6480464 Acetaminophen results in increased expression of CYP7A1 mRNA CTD PMID:36150480 paracetamol multiple interactions ISO RGD:69210 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP7A1 mRNA, kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] CTD PMID:33819548 , PMID:36150480 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 , PMID:17202762 paracetamol decreases expression ISO RGD:10458 6480464 Acetaminophen results in decreased expression of CYP7A1 mRNA CTD PMID:18544908 parathion increases expression ISO RGD:10458 6480464 Parathion results in increased expression of CYP7A1 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO RGD:10458 6480464 Pentachlorophenol results in increased expression of CYP7A1 mRNA CTD PMID:23892564 perflubutane decreases expression ISO RGD:10458 6480464 perfluorobutane results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorobutanesulfonic acid increases expression ISO RGD:10458 6480464 perfluorobutanesulfonic acid results in increased expression of CYP7A1 mRNA CTD PMID:32534104 perfluorobutyric acid increases expression EXP 6480464 perfluorobutyric acid analog results in increased expression of CYP7A1 mRNA CTD PMID:21878386 perfluorodecanoic acid decreases expression ISO RGD:69210 6480464 perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorodecanoic acid decreases expression ISO RGD:10458 6480464 perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:27344344 perfluorodecanoic acid multiple interactions ISO RGD:10458 6480464 PPARA protein affects the reaction [perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:27344344 perfluorodecanoic acid increases expression ISO RGD:10458 6480464 perfluorodecanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorododecanoic acid decreases expression ISO RGD:69210 6480464 perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorododecanoic acid decreases expression ISO RGD:10458 6480464 perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluoroheptanoic acid increases expression ISO RGD:69210 6480464 perfluoro-n-heptanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 perfluorohexanesulfonic acid decreases expression ISO RGD:10458 6480464 perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:21705711 , PMID:23567314 perfluorohexanesulfonic acid decreases expression ISO RGD:69210 6480464 perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorohexanoic acid decreases expression ISO RGD:69210 6480464 perfluorohexanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 perfluorononanoic acid decreases expression ISO RGD:69210 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 , PMID:32588087 perfluorononanoic acid decreases expression ISO RGD:10458 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:29112762 perfluorononanoic acid multiple interactions ISO RGD:10458 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of CYP7A1 mRNA CTD PMID:33483757 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:16221955 more ... perfluorooctane-1-sulfonic acid increases expression ISO RGD:69210 6480464 perfluorooctane sulfonic acid results in increased expression of CYP7A1 mRNA CTD PMID:33772556 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69210 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA, perfluorooctane sulfonic acid results in decreased expression of CYP7A1 protein CTD PMID:27153767 , PMID:32253466 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10458 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:19429403 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10458 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA, PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20936131 , PMID:36331819 perfluorooctanesulfonamide increases expression ISO RGD:69210 6480464 perfluorooctanesulfonamide analog results in increased expression of CYP7A1 mRNA CTD PMID:35337807 perfluorooctanoic acid multiple interactions ISO RGD:10458 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20936131 perfluorooctanoic acid increases expression ISO RGD:69210 6480464 perfluorooctanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:33772556 perfluorooctanoic acid decreases expression ISO RGD:69210 6480464 perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA, perfluorooctanoic acid results in decreased expression of CYP7A1 protein CTD PMID:23567314 more ... perfluorooctanoic acid decreases expression ISO RGD:10458 6480464 perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:17681415 more ... perfluoropentanoic acid increases expression ISO RGD:69210 6480464 perfluoropentanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 perfluoroundecanoic acid decreases expression ISO RGD:69210 6480464 perfluoroundecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of CYP7A1 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:69210 6480464 Phenobarbital affects the expression of CYP7A1 mRNA CTD PMID:15629111 phenobarbital increases expression ISO RGD:69210 6480464 Phenobarbital results in increased expression of CYP7A1 mRNA CTD PMID:22258563 phenobarbital multiple interactions ISO RGD:10458 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP7A1 mRNA CTD PMID:24535843 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP7A1 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:10458 6480464 Phenobarbital results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 phenobarbital increases expression ISO RGD:10458 6480464 Phenobarbital results in increased expression of CYP7A1 mRNA CTD PMID:19270015 phenytoin multiple interactions ISO RGD:10458 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69210 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 phosphatidylcholine increases activity EXP 6480464 Phosphatidylcholines results in increased activity of CYP7A1 protein CTD PMID:12559476 pioglitazone multiple interactions ISO RGD:10458 6480464 pioglitazone promotes the reaction [U 0126 results in increased expression of CYP7A1 mRNA], U 0126 promotes the reaction [pioglitazone results in increased expression of CYP7A1 mRNA] CTD PMID:22593575 pioglitazone increases expression ISO RGD:10458 6480464 pioglitazone results in increased expression of CYP7A1 mRNA CTD PMID:22593575 pirinixic acid multiple interactions ISO RGD:10458 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA], PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:15777286 more ... pirinixic acid decreases expression ISO RGD:69210 6480464 pirinixic acid results in decreased expression of CYP7A1 mRNA CTD PMID:31676336 pirinixic acid decreases expression ISO RGD:10458 6480464 pirinixic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15777286 more ... pirinixic acid increases expression ISO RGD:10458 6480464 pirinixic acid results in increased expression of CYP7A1 mRNA CTD PMID:20936131 pregnenolone decreases activity EXP 6480464 Pregnenolone results in decreased activity of CYP7A1 protein CTD PMID:1175606 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10458 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 more ... pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:10458 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20359477 prochloraz decreases expression ISO RGD:69210 6480464 prochloraz results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 procymidone affects expression ISO RGD:10458 6480464 procymidone affects the expression of CYP7A1 mRNA CTD PMID:36764477 propiconazole increases expression ISO RGD:10458 6480464 propiconazole results in increased expression of CYP7A1 mRNA CTD PMID:21278054 propiconazole decreases expression ISO RGD:69210 6480464 propiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 , PMID:36291160 prothioconazole increases expression ISO RGD:10458 6480464 prothioconazole results in increased expression of CYP7A1 mRNA CTD PMID:36007749 Prothioconazole-desthio increases expression ISO RGD:10458 6480464 prothioconazole-desthio results in increased expression of CYP7A1 mRNA CTD PMID:36007749 psoralen decreases expression EXP 6480464 Ficusin results in decreased expression of CYP7A1 mRNA, Ficusin results in decreased expression of CYP7A1 protein CTD PMID:30597224 puerarin multiple interactions EXP 6480464 puerarin affects the reaction [Lead affects the expression of CYP7A1] CTD PMID:22001170 PX-866 multiple interactions ISO RGD:10458 6480464 [PX-866 co-treated with SORT1 protein] results in decreased expression of CYP7A1 mRNA CTD PMID:25805502 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP7A1 mRNA, Pyrazinamide results in increased expression of CYP7A1 protein CTD PMID:27255380 pyrazinecarboxamide multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 pyrazinecarboxamide multiple interactions ISO RGD:69210 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein CTD PMID:35835356 pyrrolidines decreases expression EXP 6480464 Pyrrolidines analog results in decreased expression of CYP7A1 mRNA CTD PMID:26365562 resveratrol multiple interactions ISO RGD:10458 6480464 [Resveratrol results in increased activity of NR1H3 protein] which results in increased expression of CYP7A1 mRNA more ... CTD PMID:22607622 , PMID:31298478 resveratrol increases expression ISO RGD:10458 6480464 resveratrol results in increased expression of CYP7A1 mRNA CTD PMID:22607622 , PMID:23146569 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA], resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] CTD PMID:25418378 rifampicin multiple interactions ISO RGD:10458 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 rifampicin multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 rifampicin multiple interactions ISO RGD:69210 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein, NR1I2 protein promotes the reaction [Rifampin results in decreased expression of CYP7A1 mRNA] CTD PMID:21127053 , PMID:35835356 rifampicin decreases expression ISO RGD:69210 6480464 Rifampin results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 more ... rifaximin multiple interactions ISO RGD:69210 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CYP7A1 protein CTD PMID:22790967 ritonavir decreases expression ISO RGD:69210 6480464 Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:26626330 ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:17719200 rotenone affects expression EXP 6480464 Rotenone affects the expression of CYP7A1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69210 6480464 [S-(1 more ... CTD PMID:35811015 Salidroside multiple interactions ISO RGD:10458 6480464 rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] CTD PMID:32251705 saracatinib increases expression ISO RGD:69210 6480464 saracatinib results in increased expression of CYP7A1 mRNA CTD PMID:20371703 saracatinib multiple interactions ISO RGD:69210 6480464 saracatinib inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:20371703 selenium atom multiple interactions EXP 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 selenium atom multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:24641316 senecionine decreases expression ISO RGD:10458 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:31606820 senecionine decreases expression ISO RGD:69210 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 Senkirkine decreases expression ISO RGD:69210 6480464 senkirkine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of CYP7A1 mRNA CTD PMID:15967596 simvastatin multiple interactions EXP 6480464 Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA], Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 protein] CTD PMID:33383043 sodium arsenite decreases expression ISO RGD:10458 6480464 sodium arsenite results in decreased expression of CYP7A1 mRNA CTD PMID:31532247 sodium arsenite decreases expression ISO RGD:69210 6480464 sodium arsenite results in decreased expression of CYP7A1 mRNA CTD PMID:29301061 sodium cholate multiple interactions ISO RGD:10458 6480464 [Sodium Cholate co-treated with Dietary Fats] results in decreased expression of CYP7A1 mRNA CTD PMID:23665937 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of CYP7A1 mRNA CTD PMID:12325037 soybean oil increases activity EXP 6480464 Soybean Oil results in increased activity of CYP7A1 protein CTD PMID:12559476 spironolactone decreases activity EXP 6480464 Spironolactone results in decreased activity of CYP7A1 protein CTD PMID:15652244 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP7A1 mRNA CTD PMID:10393316 streptozocin increases expression ISO RGD:10458 6480464 Streptozocin results in increased expression of CYP7A1 mRNA CTD PMID:34896238 streptozocin multiple interactions ISO RGD:10458 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:29382564 , PMID:34896238 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:31100278 sulfluramid increases expression ISO RGD:69210 6480464 sulfluramid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 sulforaphane decreases expression ISO RGD:69210 6480464 sulforaphane results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 Sunset Yellow FCF multiple interactions ISO RGD:69210 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 tamoxifen affects expression ISO RGD:10458 6480464 Tamoxifen affects the expression of CYP7A1 mRNA CTD PMID:20937368 tartrazine multiple interactions ISO RGD:69210 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 taurocholic acid multiple interactions ISO RGD:10458 6480464 FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA], NR1H4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:16284190 taurocholic acid decreases expression EXP 6480464 Taurocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:7832767 taurocholic acid decreases expression ISO RGD:10458 6480464 Taurocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:16284190 tebuconazole decreases expression ISO RGD:69210 6480464 tebuconazole results in decreased expression of CYP7A1 mRNA CTD PMID:30458266 more ... tectorigenin multiple interactions ISO RGD:10458 6480464 tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA], tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 protein] CTD PMID:35390440 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CYP7A1 mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:10458 6480464 Testosterone results in decreased expression of CYP7A1 mRNA CTD PMID:21669218 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 , PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP7A1 mRNA CTD PMID:30723492 tetrachloromethane increases expression ISO RGD:10458 6480464 Carbon Tetrachloride results in increased expression of CYP7A1 mRNA CTD PMID:29987408 tetrachloromethane multiple interactions EXP 6480464 1 more ... CTD PMID:31150632 , PMID:35872049 tetrachloromethane decreases expression ISO RGD:10458 6480464 Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline increases expression ISO RGD:10458 6480464 Tetracycline results in increased expression of CYP7A1 mRNA CTD PMID:16917069 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 thiacloprid multiple interactions EXP 6480464 [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA, [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 thiacloprid decreases expression ISO RGD:69210 6480464 thiacloprid results in decreased expression of CYP7A1 protein CTD PMID:32194361 thiacloprid decreases expression EXP 6480464 thiacloprid results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 thiamethoxam decreases expression ISO RGD:69210 6480464 Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CYP7A1 mRNA CTD PMID:26222700 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP7A1 mRNA CTD PMID:34492290 thiram decreases expression ISO RGD:69210 6480464 Thiram results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 titanium dioxide decreases expression ISO RGD:10458 6480464 titanium dioxide results in decreased expression of CYP7A1 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:10458 6480464 Resveratrol promotes the reaction [titanium dioxide results in decreased expression of CYP7A1 mRNA] CTD PMID:31298478 toluene affects expression EXP 6480464 Toluene affects the expression of CYP7A1 mRNA CTD PMID:18653662 tributylstannane increases expression ISO RGD:10458 6480464 tributyltin results in increased expression of CYP7A1 mRNA CTD PMID:31939706 Tributyltin oxide decreases expression ISO RGD:10458 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CYP7A1 mRNA CTD PMID:18958704 trichloroethene increases expression ISO RGD:10458 6480464 Trichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:19254012 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP7A1 mRNA CTD PMID:33387578 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of CYP7A1 gene CTD PMID:27618143 trichloroethene decreases expression ISO RGD:10458 6480464 Trichloroethylene results in decreased expression of CYP7A1 mRNA CTD PMID:25549359 triclosan multiple interactions ISO RGD:69210 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP7A1 mRNA CTD PMID:30589522 triphenyl phosphate affects expression ISO RGD:10458 6480464 triphenyl phosphate affects the expression of CYP7A1 mRNA CTD PMID:36563926 Triptolide decreases expression ISO RGD:10458 6480464 triptolide results in decreased expression of CYP7A1 mRNA CTD PMID:32987112 Triptolide multiple interactions ISO RGD:10458 6480464 TRAJ18 protein affects the reaction [triptolide results in decreased expression of CYP7A1 mRNA] CTD PMID:32987112 tris(2-butoxyethyl) phosphate decreases expression ISO RGD:69210 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of CYP7A1 mRNA CTD PMID:29024780 tris(2-chloroethyl) phosphate decreases expression ISO RGD:10458 6480464 tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA CTD PMID:35780845 tris(2-chloroethyl) phosphate multiple interactions ISO RGD:10458 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] CTD PMID:35780845 troglitazone decreases expression ISO RGD:69210 6480464 troglitazone results in decreased expression of CYP7A1 mRNA CTD PMID:19631733 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP7A1 mRNA CTD PMID:21515302 trovafloxacin multiple interactions ISO RGD:10458 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CYP7A1 mRNA CTD PMID:18930950 urethane decreases expression ISO RGD:69210 6480464 Urethane results in decreased expression of CYP7A1 mRNA CTD PMID:28818685 ursodeoxycholic acid multiple interactions EXP 6480464 [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA, Ursodeoxycholic Acid inhibits the reaction [Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA] CTD PMID:16487557 , PMID:21274875 ursodeoxycholic acid decreases expression ISO RGD:10458 6480464 Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20671298 , PMID:25582706 ursodeoxycholic acid decreases expression ISO RGD:69210 6480464 Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 , PMID:21274875 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP7A1 mRNA CTD PMID:16764892 ursodeoxycholic acid multiple interactions ISO RGD:69210 6480464 Tretinoin promotes the reaction [Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA], Ursodeoxycholic Acid promotes the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] CTD PMID:21274875 usnic acid multiple interactions ISO RGD:69210 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 mRNA CTD PMID:22777745 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of CYP7A1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:69210 6480464 Valproic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:29154799 , PMID:29501571 vancomycin multiple interactions ISO RGD:10458 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:24657338 , PMID:36464106 Yangonin decreases expression ISO RGD:10458 6480464 yangonin results in decreased expression of CYP7A1 mRNA CTD PMID:29660435 Yangonin multiple interactions ISO RGD:10458 6480464 NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]] more ... CTD PMID:29660435 zinc atom multiple interactions ISO RGD:69210 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 zinc atom decreases activity EXP 6480464 Zinc results in decreased activity of CYP7A1 protein CTD PMID:1175606 zinc atom increases expression ISO RGD:69210 6480464 Zinc deficiency results in increased expression of CYP7A1 mRNA CTD PMID:18356318 zinc pyrithione increases expression ISO RGD:69210 6480464 pyrithione zinc results in increased expression of CYP7A1 mRNA CTD PMID:21424779 zinc(0) multiple interactions ISO RGD:69210 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 zinc(0) increases expression ISO RGD:69210 6480464 Zinc deficiency results in increased expression of CYP7A1 mRNA CTD PMID:18356318 zinc(0) decreases activity EXP 6480464 Zinc results in decreased activity of CYP7A1 protein CTD PMID:1175606